A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate in the Treatment of Patients With COPD

PHASE3CompletedINTERVENTIONAL
Enrollment

345

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2006

Conditions
COPD
Interventions
DRUG

Formoterol Fumarate

Trial Locations (44)

13031

Research Site, Camillus

23225

Research Site, Richmond

28207

Research Site, Charlotte

29307

Research Site, Spartanburg

30189

Research Site, Woodstock

32720

Research Site, DeLand

33603

Research Site, Tampa

33765

Research Site, Clearwater

35501

Research Site, Jasper

41042

Research Site, Florence

43215

Research Site, Columbus

45241

Research Site, Cincinnati

48106

Research Site, Ann Arbor

53209

Research Site, Milwaukee

53792

Research Site, Madison

55402

Research Site, Minneapolis

55905

Research Site, Rochester

59701

Research Site, Butte

60141

Research Site, Hines

61761

Research Site, Normal

63122

Research Site, St Louis

63301

Research Site, Saint Charles

70115

Research Site, New Orleans

75231

Research Site, Dallas

78229

Research Site, San Antonio

80033

Research Site, Wheat Ridge

80206

Research Site, Denver

85715

Research Site, Tuscon

87108

Research Site, Albuquerque

89014

Research Site, Henderson

90048

Research Site, Los Angeles

90620

Research Site, Buena Park

90806

Research Site, Long Beach

90813

Research Site, Long Beach

92120

Research Site, San Diego

92647

Research Site, Huntington Beach

95207

Research Site, Stockton

97213

Research Site, Portland

97504

Research Site, Medford

85006-2666

Research Site, Phoenix

06105

Research Site, Hartford

08003

Research Site, Cherry Hill

07901

Research Site, Summit

02920

Research Site, Cranston

All Listed Sponsors
lead

Dey

INDUSTRY

NCT00215436 - A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate in the Treatment of Patients With COPD | Biotech Hunter | Biotech Hunter